CLVS

Clovis Oncology, Inc. Competitors

$68.13
*  
3.39
5.24%
Get CLVS Alerts
*Delayed - data as of Jan. 26, 2015 15:20 ET  -  Find a broker to begin trading CLVS now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    CLVS Real Time
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks

Competitor Industry: Major Pharmaceuticals

Clovis Oncology, Inc.
CompanyName
Symbol: Market
LastSale NetChange ▼ Volume Today's High / Low 52 Weeks High / Low P / E Ratio Market Cap
Intercept Pharmaceuticals, Inc.
ICPT: NASDAQ-GS
$ 174.50 8.74 ▲ 537,285 $ 177.50
$ 165.89
$ 484.99
$ 128.50
NE 3,702,541,000
Pharmacyclics, Inc.
PCYC: NASDAQ-GS
$ 166.28 7.73 ▲ 908,593 $ 167.28
$ 158.01
$ 159.99
$ 82.51
152.55 12,560,624,920
Ultragenyx Pharmaceutical Inc.
RARE: NASDAQ-GS
$ 58.0414 5.83 ▲ 320,111 $ 58.98
$ 50.83
$ 69.7738
$ 32.02
NE 1,851,462,619
Actavis, Inc.
ACT: NYSE
$ 284.37 5.25 ▲ 1,999,624 $ 284.74
$ 276.88
$ 280.24
$ 174.94
NE 75,375,396,570
Shire plc
SHPG: NASDAQ-GS
$ 220.37 4.34 ▲ 1,471,975 $ 221.35
$ 218.32
$ 264.98
$ 141.66
33.44 43,969,764,990
Receptos, Inc.
RCPT: NASDAQ-GS
$ 114.11 4.01 ▲ 269,848 $ 116.19
$ 108.294
$ 139.40
$ 24.5345
NE 3,594,350,890
Allergan, Inc.
AGN: NYSE
$ 227.81 3.64 ▲ 1,398,135 $ 228.02
$ 223.27
$ 224.28
$ 110.62
53.1 67,864,371,190
Clovis Oncology, Inc.
CLVS: NASDAQ-GS
$ 68.13 3.39 ▲ 286,258 $ 68.53
$ 64.25
$ 93.33
$ 35.33
NE 2,313,967,320
Agios Pharmaceuticals, Inc.
AGIO: NASDAQ-GS
$ 126.81 3.16 ▲ 249,283 $ 127.9399
$ 122.589
$ 138.85
$ 25.05
NE 4,398,151,230
Lannett Co Inc
LCI: NYSE
$ 48.83 3.15 ▲ 1,035,268 $ 50.567
$ 46.82
$ 59.44
$ 29.12
18.29 1,746,063,140
Mylan Inc.
MYL: NASDAQ-GS
$ 56.90 2.69 ▲ 4,609,353 $ 57.04
$ 54.02
$ 59.60
$ 42.43
24.53 21,296,190,600
Sage Therapeutics, Inc.
SAGE: NASDAQ-GM
$ 40.34 2.09 ▲ 175,713 $ 41.27
$ 35.31
$ 47.7592
$ 24.25
NE 1,040,489,620
Five Prime Therapeutics, Inc.
FPRX: NASDAQ-GS
$ 26.97 2.02 ▲ 310,427 $ 27.25
$ 25.01
$ 28.47
$ 10.50
NE 675,409,710
Regeneron Pharmaceuticals, Inc.
REGN: NASDAQ-GS
$ 422.07 1.86 ▲ 338,005 $ 427.45
$ 417.01
$ 437.6384
$ 267.56
142.59 42,077,002,440
Heat Biologics, Inc.
HTBX: NASDAQ-CM
$ 5.79 1.70 ▲ 537,499 $ 6.18
$ 4.30
$ 8.74
$ 3.60
NE 37,530,780
Tetraphase Pharmaceuticals, Inc.
TTPH: NASDAQ-GS
$ 35.29 1.68 ▲ 422,658 $ 35.69
$ 32.62
$ 44.55
$ 8.01
NE 1,081,920,820
TESARO, Inc.
TSRO: NASDAQ-GS
$ 42.45 1.65 ▲ 354,968 $ 42.60
$ 40.80
$ 43.92
$ 22.1501
NE 1,530,831,900
Forward Pharma A/S
FWP: NASDAQ-GS
$ 23.43 1.61 ▲ 16,837 $ 23.43
$ 22.02
$ 26.025
$ 15.75
NE 1,073,422,020
Alnylam Pharmaceuticals, Inc.
ALNY: NASDAQ-GS
$ 95.01 1.59 ▲ 708,257 $ 96.20
$ 93.41
$ 111.49
$ 47.03
NE 7,309,214,310
BioMarin Pharmaceutical Inc.
BMRN: NASDAQ-GS
$ 99.28 1.59 ▲ 999,860 $ 100.48
$ 97.50
$ 100.50
$ 55.04
NE 14,640,424,480
NeuroDerm Ltd.
NDRM: NASDAQ-GM
$ 11.42 1.59 ▲ 705,735 $ 12.25
$ 9.8601
$ 19.07
$ 5.67
NE 194,105,740
Anacor Pharmaceuticals, Inc.
ANAC: NASDAQ-GM
$ 35.735 1.59 ▲ 437,881 $ 36.18
$ 34.15
$ 37.4499
$ 13.19
30.28 1,532,924,295
Isis Pharmaceuticals, Inc.
ISIS: NASDAQ-GS
$ 72.80 1.52 ▲ 1,682,785 $ 73.75
$ 70.5801
$ 75.24
$ 22.25
NE 8,600,664,800
Ligand Pharmaceuticals Incorporated
LGND: NASDAQ-GM
$ 56.005 1.34 ▲ 178,884 $ 56.60
$ 54.28
$ 80.42
$ 41.99
175.02 1,121,388,115
Salix Pharmaceuticals, Ltd.
SLXP: NASDAQ-GS
$ 127.255 1.34 ▲ 585,837 $ 127.87
$ 125.22
$ 172.98
$ 86
NE 8,109,070,365